drugset / Trial / NCT03158623

Wound Additives in Primary Total Joint Athroplasty

NCT03158623

Phase 3 Completed 90 enrolled Salt Lake Orthopedic Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

3 cohorts of total joint patient of 30 members each were randomized to receive PRP or Activated Collegen or no additive were studied for status of the wound at 6 weeks and recorded all complications, infections and reoperations. The three groups were than compared for statistical analysis

Timeline

Start
2016-04-01
Primary completion
2016-12-06
Completion
2016-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cellerate Unknown 1 g
Subject Platelet Rich Plasma Other / unclassified 30 ml

Indications